Active

STEDIPHAR

Switched

BE0477059361

Rechtspersoon Private limited company 1 establishment

Nieuwpoortsesteenweg 70, 8400 Oostende Detailhandel in farmaceutische producten

Active for

24 year, 5 months

Financials

Financial year 2025

Gross margin

€ 391,214

▲ 12% vs 2024

Profit

Healthy

€ 207,443

▼ 8% vs 2024

Debts

Normal

€ 760,475

▼ 24% vs 2024

STEDIPHAR from Oostende, company number BE0477059361, closed financial year 2025 with a result of € 207,443 after tax. For that financial year STEDIPHAR recorded a gross margin of € 391,214 and equity of € 325,335. Compared with financial year 2024, the result moved from € 226,168 to € 207,443. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What happened at STEDIPHAR?

What happened at STEDIPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 207,443 (▼ 8% vs 2024). filed late Source: NBB ↗
  • New establishment in Oostende. KBO
  • Start of the company according to the CBE. KBO

In short

From € 394,800 profit in 2021 to € 207,443 profit in 2025.

Paid € 123,677 in corporate taxes since 2021.

Best year ever: 2021, with € 394,800 profit.

On average € 205,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at STEDIPHAR? We notify you, reason included.

Follow STEDIPHAR

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

MEULEMEESTER STEVEN BV
MEULEMEESTER DIDRIK BV
STEDIPHAR
Farmadistri
Bobbie Pharmaceutical Services
FARMAZORG
+2

Behind STEDIPHAR are MEULEMEESTER STEVEN BV and MEULEMEESTER DIDRIK BV. The same people are also behind Farmadistri, Bobbie Pharmaceutical Services, FARMAZORG, DISTEPHAR and MEDIPACK.

See the full network in the app

Directors

According to the 2025 annual accounts

MEULEMEESTER STEVEN BV

Administrator-manager · represented by STEVEN WIM MEULEMEESTER

Also active at: Farmadistri, Bobbie Pharmaceutical Services, FARMAZORG +2 more

MEULEMEESTER DIDRIK BV

Administrator-manager · represented by DIDRIK MEULEMEESTER

Also active at: Farmadistri, Bobbie Pharmaceutical Services, FARMAZORG +1 more

Establishments

Establishment units

Physical locations of this company

Registered office

Nieuwpoortsesteenweg 70

8400 Oostende

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0477.059.361
VAT number
BE 0477.059.361
Registered office
Nieuwpoortsesteenweg 70, 8400 Oostende
Names & denominations
STEDIPHAR
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
11 March 2002
Peppol
Active · Active since 15 Jul 2025
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of STEDIPHAR?
The enterprise number of STEDIPHAR is BE0477059361.
What is the address of STEDIPHAR?
The registered office of STEDIPHAR is located at Nieuwpoortsesteenweg 70, 8400 Oostende.
When was STEDIPHAR founded?
STEDIPHAR was founded on 11 March 2002.
What is the main activity of STEDIPHAR?
The main activity of STEDIPHAR is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does STEDIPHAR have a website?
No website is currently known for STEDIPHAR.
How much profit did STEDIPHAR make in 2025?
STEDIPHAR posted a profit after taxes of € 207,443 in financial year 2025.
What is the revenue of STEDIPHAR?
As a small company, STEDIPHAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 391,214.
How many employees does STEDIPHAR have?
According to the 2025 annual accounts, STEDIPHAR has 1.9 full-time equivalents (FTE).
Where can I find the annual accounts of STEDIPHAR?
STEDIPHAR files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of STEDIPHAR?
According to the 2025 annual accounts, the directors of STEDIPHAR are: MEULEMEESTER STEVEN BV, MEULEMEESTER DIDRIK BV.
Who owns STEDIPHAR?
Behind STEDIPHAR are MEULEMEESTER STEVEN BV and MEULEMEESTER DIDRIK BV. The same people are also behind Farmadistri, Bobbie Pharmaceutical Services, FARMAZORG, DISTEPHAR and MEDIPACK.